OTC · Technology

Avai Bio, Inc. (AVAI)

It posted a net loss of $2.8M. At June 30, 2026 it held $83.6K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch AVAI in 60 seconds

Price

$0.13

-1.89% on the day · September 28, 2026

52-week range $0.10 to $0.80

Market cap

$19.2M

What Avai Bio, Inc. does

Avai Bio, Inc. is registered with the SEC under industry code SIC 7374 (Services-Computer Processing & Data Preparation). Its shares trade on OTC under the ticker AVAI.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2026	n/a	-$1.7M	-$1.7M	-$0.01	n/a
2025	n/a	-$1.1M	-$1.1M	-$0.01	n/a
2024	n/a	-$2.1M	-$2.1M	-$0.02	n/a
2022	$276.3K	-$348.9K	-$348.9K	$0.00	n/a
2022	n/a	$126.5K	-$126.5K	$0.00	n/a
2021	n/a	$302.3K	-$302.3K	$0.00	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar

Dividends

Avai Bio, Inc. paid $0.03 per share in fiscal 2019.

Fiscal year	Per share	Paid out	Of profit
2019	$0.03	n/a	n/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Avai Bio, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 13, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.00 versus $0.00.
July 14, 2026
Annual report 10-K · period to March 31, 2026Diluted EPS -$0.01 versus -$0.01.
June 30, 2026
Late annual report notice NT 10-K
May 8, 2026
Material agreement 8-K
February 12, 2026
Quarterly report 10-Q · period to December 31, 2025Diluted EPS $0.00 versus $0.00.
February 9, 2026
Other event 8-K
November 14, 2025
Quarterly report 10-Q · period to September 30, 2025Diluted EPS $0.00 versus -$0.01.
November 4, 2025
Material agreement 8-K
September 18, 2025
Material agreement 8-K
September 17, 2025
Other event 8-K

All filings on SEC EDGAR

Questions about AVAI

What does Avai Bio, Inc. do?

Avai Bio, Inc. is registered with the SEC under industry code SIC 7374 (Services-Computer Processing & Data Preparation). Its shares trade on OTC under the ticker AVAI.

Is Avai Bio, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $2.8M.

When did Avai Bio, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.

Similar companies

ADP

Automatic Data Processing Inc

PAGS

PagSeguro Digital Ltd.

Compare AVAI with

Compare AVAI with any company

Follow AVAI

Get an email when Avai Bio, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow AVAI: get an email when it files

Where the numbers come from

Financial figures are the values Avai Bio, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.